<i>Mycoplasma pneumoniae</i> Infections Among Children and Adolescents in Korea, 2014-2024.

ABSTRACT:

Background

Mycoplasma pneumoniae (MP) is the most common cause of community-acquired bacterial pneumonia in children. Macrolides are used as the first-line treatment for MP infection, but resistance has increased significantly over the past few decades, making treatment difficult. This study examines the prevalence of M. pneumoniae infections and macrolide-resistant M. pneumoniae (MRMP) rates in Korean children across three recent epidemics in Korea between 2014 and 2024.

Methods

Data from Green Cross Laboratories on M. pneumoniae polymerase chain reaction (PCR) and macrolide-resistance tests were analyzed from January 2014 to March 2024, including 425,079 MP PCR tests and 11,206 resistance tests (macrolide-resistance testing began in 2019). We ex

SUBMITTER: Eun BW 

PROVIDER: S-EPMC12540973 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature